530 related articles for article (PubMed ID: 17398263)
1. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement.
Jackson E; Bellenger N; Seddon M; Harden S; Peebles C
Clin Radiol; 2007 May; 62(5):395-403. PubMed ID: 17398263
[TBL] [Abstract][Full Text] [Related]
2. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
Mahrholdt H; Wagner A; Judd RM; Sechtem U; Kim RJ
Eur Heart J; 2005 Aug; 26(15):1461-74. PubMed ID: 15831557
[TBL] [Abstract][Full Text] [Related]
3. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
[TBL] [Abstract][Full Text] [Related]
6. Correlation of magnetic resonance imaging with histopathology in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).
Tung K; Raman SV; King MA; Dephilip RM
Clin Anat; 2006 Jan; 19(1):44-50. PubMed ID: 16258971
[TBL] [Abstract][Full Text] [Related]
7. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
Amano Y; Matsumura Y; Kumita S
J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
[TBL] [Abstract][Full Text] [Related]
8. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
[TBL] [Abstract][Full Text] [Related]
10. [Cardiomyopathy and cardiac magnetic resonance].
Locca D; Jeanrenaud X; Schwitter J; Girod G; Monney P; De Palma R; Rizzo E; Prasad SK; Vogt P
Rev Med Suisse; 2009 Oct; 5(221):2051-7. PubMed ID: 19911692
[TBL] [Abstract][Full Text] [Related]
11. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease.
Marcu CB; Nijveldt R; Beek AM; Van Rossum AC
Heart Lung Circ; 2007 Apr; 16(2):70-8. PubMed ID: 17317312
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance imaging: current applications and future directions.
Desai MY; Lima JA; Bluemke DA
Methods Enzymol; 2004; 386():122-48. PubMed ID: 15120249
[No Abstract] [Full Text] [Related]
13. The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies.
Masci PG; Dymarkowski S; Bogaert J
J Cardiovasc Med (Hagerstown); 2008 May; 9(5):435-49. PubMed ID: 18403995
[TBL] [Abstract][Full Text] [Related]
14. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
15. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease.
Bucciarelli-Ducci C; Wu E; Lee DC; Holly TA; Klocke FJ; Bonow RO
Curr Probl Cardiol; 2006 Feb; 31(2):128-68. PubMed ID: 16413381
[No Abstract] [Full Text] [Related]
17. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
Kwong RY; Korlakunta H
Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cardiac magnetic resonance imaging: Update 2010.
Hombach V; Merkle N; Bernhard P; Rasche V; Rottbauer W
Cardiol J; 2010; 17(6):549-57. PubMed ID: 21154256
[TBL] [Abstract][Full Text] [Related]
19. MRI in the assessment of non ischemic myocardial diseases.
De Smet K; Verdries D; Tanaka K; De Mey J; De Maeseneer M
Eur J Radiol; 2012 Jul; 81(7):1546-8. PubMed ID: 21392911
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
